MDF EOI Application Review

Service Description

Is your MDF EOI application is competitive? This review is designed to help applicants identify strengths, risks and priority improvements before submission. Who this is for? This service is suited to Australian medtech founders, CEOs and teams who are: • preparing an MDF EOI application • unsure whether their application is competitive • seeking an external assessor-style review before submission • wanting to identify gaps, risks and inconsistencies • looking to strengthen their positioning, evidence and policy alignment • short on time and needing clear, practical recommendations What we review We review your draft MDF EOI application and supporting documents against the MDF requirements, assessment criteria and policy alignment signals. What’s included • Expert review of your MDF EOI Application • 45-minute 1:1 call with Dr Megan O’Connor to go over the review with your team • A review report with identified strengths and weaknesses of your application. Key outcomes By the end of the review, you will have: • a clear view of whether your MDF EOI is strong, borderline or not ready • a practical understanding of the application’s key risks • a prioritised action list for improving competitiveness • clearer alignment with MDF objectives and NSW Health policy priorities • specific questions to help strengthen weak or under-evidenced sections • sharper positioning before submission Why this matters MDF applications are assessed for more than eligibility. Competitive applications need to demonstrate a credible, evidence-backed commercialisation opportunity that can improve patient care, deliver NSW benefit and progress a medical device towards market.